Vanguard Fiduciary Trust
JSPR icon

Vanguard Fiduciary Trust’s Jasper Therapeutics JSPR Stock Holding History

Vanguard Fiduciary Trust’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.1K Hold
149,943
– – ﹤0.01% 3819
2026
Q1 		$131K Buy
+149,943
New +$208K ﹤0.01% 3651

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust's JSPR Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Jasper Therapeutics (JSPR) position steady in Q2 2026 at 149,943 shares worth $63.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3819.

Vanguard Fiduciary Trust first reported a position in JSPR in Q1 2026 and has held it in 2 quarters since. The position peaked at $131K in Q1 2026. 44 funds tracked by Wall St. Rank hold JSPR as of Q2 2026.

  • Vanguard Fiduciary Trust held 149,943 shares of Jasper Therapeutics worth $63.1K as of Q2 2026.
  • Vanguard Fiduciary Trust left its Jasper Therapeutics share count unchanged in Q2 2026.
  • Jasper Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3819 holding.
  • Vanguard Fiduciary Trust first reported a position in Jasper Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Jasper Therapeutics position peaked at $131K in Q1 2026.
  • 44 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.